Development of A9/A10 dopamine neurons during the second and third trimesters in the African green monkey

Journal of Comparative Neurology

Volumn 488, Issue 2, 2005, Pages 215-223

  Morrow, Bret A ^a   Redmond Jr , D Eugene ^a   Roth, Robert H ^a   Elsworth, John D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fetal; Prenatal; Primate; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

BIOLOGICAL MARKER; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN MATURATION; CELL COUNT; CELL SIZE; CELL VOLUME; CENTRAL NERVOUS SYSTEM DISEASE; CERCOPITHECIDAE; COMPARATIVE STUDY; DOPAMINERGIC NERVE CELL; FEMALE; FETUS; GESTATIONAL AGE; HEMISPHERE; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEREOMETRY;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CELL COUNT; CELL SIZE; CERCOPITHECUS AETHIOPS; DOPAMINE; EMBRYO; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; MESENCEPHALON; NEURONS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; TYROSINE 3-MONOOXYGENASE;

EID: 20544459362     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20599     Document Type: Article

References (61)

1. Akil M, Edgar CL, Pierri JN, Casali S, Lewis DA. 2000. Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biol Psychiatry 47:361-370.
2. Barker RA, Dunnett SB, Faissner A, Fawcett JW. 1996. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp Neurol 141: 79-93.
3. Berger B, Caspar P, Verney C. 1991. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci 14:21-27.
4. Betarbet R, Turner R, Chockkan V, DeLong MR, Allers KA, Walters J, Levey AI, Greenamyre JT. 1997. Dopaminergic neurons intrinsic to the primate striatum. J Neurosci 17:6761-6768.
5. Brundin P, Karlsson J, Emgard M, Schierle GS, Hansson O, Petersen A, Castilho RF. 2000. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant 9:179-195.
6. Bundock EA. 1999. Development of mesencephalic dopamine neurons in the African green monkey. Ph.D. Dissertation. Chicago: Chicago Medical School.
7. Burbach JP, Smits S, Smidt MP. 2003. Transcription factors in the development of midbrain dopamine neurons. Ann N Y Acad Sci 991:61-68.
8. Carvey PM, Chang Q, Lipton JW, Ling Z. 2003. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front Biosci 8:s826-837.
9. Di Porzio U, Zuddas A, Cosenza-Murphy DB, Barker JL. 1990. Early appearance of tyrosine hydroxylase immunoreactive cells in the mesencephalon of mouse embryos. Int J Dev Neurosci 8:523-532.
10. Elsworth JD, Brittan MS, Taylor JR, Sladek JR Jr, al-Tikriti MS, Zea-Ponce Y, Innis RB, Redmond DE Jr, Roth RH. 1996. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys. Cell Transplant 5:315-325.
11. Emborg ME, Ma SY, Mufson EJ, Levey AI, Taylor MD, Brown WD, Holden JE, Kordower JH. 1998. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J Comp Neurol 401:253-265.
12. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Hardy K, Hankerson JG, Doudet DJ, Cohen RM. 1996. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med 334:1568-1572.
13. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM. 1998. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci 18:5901-5907.
14. Freeman TB, Spence MS, Boss BD, Spector DH, Strecker RE, Olanow CW, Kordower JH. 1991. Development of dopaminergic neurons in the human substantia nigra. Exp Neurol 113:344-353.
15. Freeman TB, Sanberg PR, Nauert GM, Boss BD, Spector D, Olanow CW, Kordower JH. 1995. The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant 4:141-154.
16. Garver DL, Sladek JR Jr. 1975. Monoamine distribution in primate brain. I. Catecholamine-containing perikarya in the brain stem of Macaca speciosa. J Comp Neurol 159:289-304.
17. Gerhardt GA, Cass WA, Yi A, Zhang Z, Gash DM. 2002. Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys. J Neurochem 80:168-177.
18. German DC, Dubach M, Askari S, Speciale SG, Bowden DM. 1988. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? Neuroscience 24:161-174.
19. Granholm AC, Mott JL, Bowenkamp K, Eken S, Henry S, Hoffer BJ, Lapchak PA, Palmer MR, van Horne C, Gerhardt GA. 1997. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp Brain Res 116:29-38.
20. Grondin R, Zhang Z, Yi A, Cass WA, Maswood N, Andersen AH, Elsberry DD, Klein MC, Gerhardt GA, Gash DM. 2002. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 125:2191-2201.
21. Gundersen HJ. 1988. The nucleator. J Microsc 151(Pt 1):3-21.
22. Henderson BT, Clough CG, Hughes RC, Hitchcock ER, Kenny BG. 1991. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch Neurol 48:822-827.
23. Howard CV, Reed MG. 1998. Unbiased stereology: three dimensional measurement in microscopy. New York: Springer.
24. Hsu SM, Raine L, Franger H. 1981. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (peroxidase) procedures. J Histochem Cytochem 29:577-590.
25. Hynes M, Rosenthal A. 1999. Specification of dopaminergic and serotonergic neurons in the vertebrate CNS. Curr Opin Neurobiol 9:26-36.
26. Lauder JM, Bloom FE. 1974. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiation. J Comp Neurol 155:469-481.
27. Levitt P, Rakic P. 1982. The time of genesis, embryonic origin and differentiation of the brain stem monoamine neurons in the rhesus monkey. Brain Res 256:35-57.
28. Lewis DA, Seesack SR. 1997. Dopamine systems in the primate brain. In: Bloom FE, Bjorklund A, Hokfelt T, editors. The primate nervous system, part 1. Amsterdam: Elsevier. p 263-376.
29. Lieb K, Andersen C, Lazarov N, Zienecker R, Urban I, Reisert I, Pilgrim C. 1996. Pre- and postnatal development of dopaminergic neuron numbers in the male and female mouse midbrain. Brain Res Dev Brain Res 94:37-43.
30. Lloyd KG, Hornykiewicz O, Davidson L, Shannak K, Farley I, Goldstein M, Shibuya M, Kelley WN, Fox IH. 1981. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med 305:1106-1111.
31. Mattock C, Marmot M, Stern G. 1988. Could Parkinson's disease follow intra-uterine influenza? a speculative hypothesis. J Neurol Neurosurg Psychiatry 51:753-756.
32. Moller A, Strange P, Gundersen HJ. 1990. Efficient estimation of cell volume and number using the nucleator and the disector. J Microsc 159:61-71.
33. Morrow BA, Elsworth JD, Roth RH. 2002. Fear-like biochemical and behavioral responses in rats to the predator odor, TMT, are dependent on the exposure environment. Synapse 46:11-18.
34. Nikkhah G, Eberhard J, Olsson M, Bjorklund A. 1995. Preservation of fetal ventral mesencephalic cells by cool storage: in-vitro viability and TH-positive neuron survival after microtransplantation to the striatum. Brain Res 687:22-34.
35. Nobin A, Bjorklund A. 1973. Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol Scand Suppl 388:1-40.
36. Olson L, Seiger A. 1972. Early prenatal ontogeny of central monoamine neurons in the rat: fluorescence histochemical observations. 137:301-316.
37. Olson L, Boreus LO, Seiger A. 1973. Histochemical demonstration and mapping of 5-hydroxytryptamine- and catecholamine-containing neuron systems in the human fetal brain. Z Anat Entwicklungsgesch 139:259-282.
38. Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY. 2002. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 20:1103-1110.
39. Pearson J, Goldstein M, Markey K, Brandeis L. 1983. Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 8:3-32.
40. Perrone-Capano C, Da Pozzo P, di Porzio U. 2000. Epigenetic cues in midbrain dopaminergic neuron development. Neurosci Biobehav Rev 24:119-124.
41. Pickel VM, Specht LA, Sumal KK, Joh TH, Reis DJ, Hervonen A. 1980. Immunocytochemical localization of tyrosine hydroxylase in the human fetal nervous system. J Comp Neurol 194:465-474.
42. Poyot T, Conde F, Gregoire MC, Frouin V, Coulon C, Fuseau C, Hinnen F, Dolle F, Hantraye P, Bottlaender M. 2001. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa. J Cereb Blood Flow Metab 21:782-792.
43. Ramsden DB, Parsons RB, Ho SL, Waring RH. 2001. The aetiology of idiopathic Parkinson's disease. Mol Pathol 54:369-380.
44. Redmond DE Jr. 2002. Cellular replacement therapy for Parkinson's disease-where are we today? Neuroscientist 8:457-488.
45. Reisert I, Schuster R, Zienecker R, Pilgrim C. 1990. Prenatal development of mesencephalic and diencephalic dopaminergic systems in the male and female rat. Brain Res Dev Brain Res 53:222-229.
46. Rosenberg DR, Lewis DA. 1995. Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis. J Comp Neurol 358:383-400.
47. Rosenstein JM. 1995. Why do neural transplants survive? An examination of some metabolic and pathophysiological considerations in neural transplantation. Exp Neurol 133:1-6.
48. Roth RH, Elsworth JD. 1995. The biochemical pharmacology of midbrain dopamine neurons. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology, the fourth generation of progress. New York: Raven Press. p 227-243.
49. Sailaja K, Gopinath G. 1994. Developing substantia nigra in human: a qualitative study. Dev Neurosci 16:44-52.
50. Silani V, Mariani D, Donato FM, Ghezzi C, Mazzucchelli F, Buscaglia M, Pardi G, Scarlato G. 1994. Development of dopaminergic neurons in the human mesencephalon and in vitro effects of basic fibroblast growth factor treatment. Exp Neurol 128:59-76.
51. Singer HS. 2000. Current issues in Tourette syndrome. Mov Disord 15: 1051-1063.
52. Sladek JR Jr, Collier TJ, Haber SN, Roth RH, Redmond DE Jr. 1986. Survival and growth of fetal catecholamine neurons transplanted into primate brain. Brain Res Bull 17:809-818.
53. Sladek JR Jr, Blanchard B, Collier TJ, Elsworth JD, Taylor JR, Roth RH, Redmond DE Jr. 1995a. Development of mesencephalic dopamine neurons in the nonhuman primate. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press. p 269-282.
54. Sladek JR Jr, Elsworth JD, Taylor JR, Roth RH, Redmond DE Jr. 1995b. Techniques for neural transplantation in non-human primates. In: Ricordi C, Landes RG, editors. Techniques for neural transplantation. Austin, TX: CRC Press. p 391-408.
55. Specht LA, Pickel VM, Joh TH, Reis DJ. 1981. Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. II. Late ontogeny. J Comp Neurol 199:255-276.
56. Tarantal AF, Hendrickx AG. 1988. Prenatal growth in the cynomolgus and rhesus macaque (Macaca fasicularis and Macaca mulatta): a comparison by ultrasonography. Am J Primatol 15:309-323.
57. Verney C, Zecevic N, Nikolic B, Alvarez C, Berger B. 1991. Early evidence of catecholaminergic cell groups in 5- and 6-week-old human embryos using tyrosine hydroxylase and dopamine-beta-hydroxylase immunocytochemistry. Neurosci Lett 131:121-124.
58. Voorn P, Kalsbeek A, Jorritsma-Byham B, Groenewegen HJ. 1988. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25:857-887.
59. Williams SM, Goldman-Rakic PS. 1998. Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex 8:321-345.
60. Witta J, Baffi JS, Palkovits M, Mezey E, Castillo SO, Nikodem VM. 2000. Nigrostriatal innervation is preserved in Nurr1-null mice, although dopaminergic neuron precursors are arrested from terminal differentiation. Brain Res Mol Brain Res 84:67-78.
61. Zhao M, Momma S, Delfani K, Carlen M, Cassidy RM, Johansson CB, Brismar H, Shupliakov O, Frisen J, Janson AM. 2003. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A 100:7925-7930.